Studies have demonstrated that either genetic deletion or pharmacological inhibition of TLR4 can effectively prevent bladder inflammation in mouse models of cyclophosphamide (CYP)-induced cystitis [15, 16]. This evidence concerns the gene TLR4 and cystitis.